Formulated with ExoSCRT™-engineered exosomes containing 96 clinically-validated miRNAs and 200+ bioactive proteins. Third-party trials demonstrate 89% improvement in skin elasticity and 78% reduction in wrinkle depth after 5 sessions. Certified medical-grade solution for epidermal regeneration (ISO 13485 compliant).

Core Technology: ExoSCRT™ purification system ensures ≥1×10^10 particles/mL exosome concentration with <95nm particle size. Synergized with 3% stabilized Vitamin C (THD ascorbate) and 2% nano-hyaluronic acid (50-100kDa).

Medical Kit Contains:
• Lyophilized exosomes: 20mg/vial (3mL reconstitution volume)
• Activation solution: 5mL sterile buffer (pH 6.2-6.8)
• Storage: 2-8°C (lyophilized), 25°C max (activated)

Treatment Protocol:
1. Reconstitute with 2x activator vials (10mL total)
2. Mesotherapy application (32G needle recommended)
3. 3-5 sessions @ 4-week intervals
4. Post-treatment: Avoid UV exposure ×48hrs

*For licensed practitioners only. Not FDA evaluated. Clinical efficacy ranges 72-89% based on Fitzpatrick skin type. Contains bioactive components – contraindicated with anticoagulant therapies. Proper disposal protocol required for medical waste.